|
中文部分
方通,潘俊芳&蔣曙光.(2007).HPLC法則定噻托溴铵及有關物質.藥學與臨床研究,124-126.
英文部分
Bancalari et al.(2005).Management of infants with bronchopulmonary dysplasia
in North America.Earl Hum Dev 81,171.
Byron PR.(2004)Drug delivery devices:issues in durg development. Proc 1,321-
328.
Cole C.(2000) Special problems in aerosol delivery:neonatal and pediatric
considerations. RespiCare 45,646-651.
Collis GG et al.(1990). Dilution of nebulised aerosols by air entrainment in
children .Lancet 336,341-343.
Cryan S-A.(2005).Carrier-based strategies for targeting protein and peptide
drugs to the lung.AAPS Journal 7,E20-41.
Fink JB.( 2004). Aerosol delivery to ventilated infant and pediatric patients.
Respir Care 49,653-665.
Garner SS et al.(2006)Effect of heliox on albuterol delivery by metered-dose
inhaler in pediatric in vitro models of mechanical ventilation.Pharmacotherapy
26, 1396-1402.
Geller D.(2005). Comparing clinical features of the nebulizer,metered-dose
inhaler, and dry powder inhaler. Respir Care 50,1313.
Greenough A.(2007).Late respieatory outcomes after preterm bith. Earl Hum Dev
83,785.
Israel Amirav et al.(2012). Deposition of small particles in the developing
lung. Paediatric Respiratory Reviews 13,73–78.
Janssens HM et al.(2003)Aerosol therapy and the fighting toddler: is
administration during sleep an alternative? J Aerosol Med 16,395-400.
Kamrun Nahar et al. (2013)In vitro, in vivo and ex vivo models for studying
particle deposition and drug absorption of inhaled pharmaceuticals. European
Journal of Pharmaceutical Sciences 49,805–818.
Kristin Tanney et.al.(2011). Extremely Low-Dose Dexamethasone to Facilitate
Extubation in Mechanically Ventilated Preterm Babies. Neonatology 100,285-289.
Leversha AM et al.(2000). Costs and effectiveness of spacer versus nebulizer
in young children with moderate and severe acute asthma. J Pediatr 136,497-502.
Lugo RA et al.(2001) Albuterol delivery in a neonatal ventilated lung model:
Nebulization versus chlorofluorocarbon- and hydrofluoroalkane-pressurized
metered dose inhalers. Pediatr Pulmonol 31,247-254.
Newman SP & Busse WW.(2002).Evolution of dry powder inhaler design,
formulation and performance. Respiratory Medicine 96,293-304.
Patton JS & Byron PR..(2007).Inhaling medicine:delivering durgs to the body
throught the lungs.Nat Rev Durg Discovery 6,67-74.
RK TRIVEDI.(2012). A Rapid, Stability-Indicating RP-HPLC Method for the
Simultaneous Determination of Formoterol Fumarate, Tiotropium Bromide, and
Ciclesonide in a Pulmonary Drug Product. Sci Pharm 80, 591–603.
Ruppel GL WD.(2003). The respiratory system. In: Scanlan CL WR, Stoller JK.
Editor: Egan’s fundamentals of respiratory care, ed 8. St. Louis,Mo, Mosby.
Tal A et al.(1996). Deposition pattern of radiolabeled salbutamol inhaled
from a metered-dose inhaler by means of a spacer with mask in young children
with airway obstruction. The Journal of pediatrics 128,479-484.
|